900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Best ever peak flow rate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bestuzhev cattle breed	Moved elsewhere
Beta 1 blocking product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta 2 glycoprotein 1 level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta 2 glycoprotein 1 level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker contraindicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker glaucoma preparation	A component that fails to comply with the current editorial guidance.
Beta blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker not indicated	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker prophylaxis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker prophylaxis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker therapy refused	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta blocker therapy refused	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta interferon	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta source contact therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta thalassaemia trait	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta thalassaemia trait	Ambiguous
Beta thalassaemia: (& minor)	Ambiguous
Beta tocopherol + gamma tocopherol	A component that is no longer current, useful, appropriate or acceptable.
Beta-adrenoceptor agonist allergy	A component that fails to comply with the current editorial guidance.
Beta-adrenoceptor blocking drug	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-aspartyl-peptidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-endorphin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-galactocerebrosidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-galactocerebrosidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-glucuronidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-glucuronidase test	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-glucuronidase test	Ambiguous
Beta-hemolytic Streptococcus, group B	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-hydroxybutyrate measurement	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Beta-hydroxyisobutyryl-coenzyme A deacylase deficiency	Ambiguous
Betaherpesvirus group	A component that is no longer current, useful, appropriate or acceptable.
Betahistine dihydrochloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betahistine hydrochloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaine, anhydrous 1g/scp powder	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone + antimicrobials	Ambiguous
Betamethasone 0.1% cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone 0.1% lotion	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone 0.1% ointment	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone 0.1% scalp application	A component that fails to comply with the current editorial guidance.
Betamethasone 0.6mg/5mL syrup	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone 4mg/mL injection solution 1mL ampule	Ambiguous
Betamethasone 500micrograms soluble tablet	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone benzoate topical preparation	A component that fails to comply with the current editorial guidance.
Betamethasone dipropionate + clotrimazole	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betamethasone dipropionate + clotrimazole 0.5mg/10mg lotion	A component that fails to comply with the current editorial guidance.
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betamethasone dipropionate 0.05% gel	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate 0.05% lotion	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate 0.5% ointment	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate 0.5mg cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate 0.5mg/g cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone dipropionate 0.5mg/g ointment	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone sodium phospha 15mg/5mL injection	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phospha 3mg/mL injection	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phospha 4mg/mL injection	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phosphate 3mg/mL injection solution 5mL vial	A component that fails to comply with the current editorial guidance.
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial	A component that fails to comply with the current editorial guidance.
Betamethasone valerate 0.12%	A component that fails to comply with the current editorial guidance.
Betamethasone valerate 0.12% aerosol	A component that fails to comply with the current editorial guidance.
Betamethasone valerate 0.12% foam	Ambiguous
Betamethasone valerate systemic preparation	Ambiguous
Betamethasone+clotrimazole 0.05/1% cream	A component that is no longer current, useful, appropriate or acceptable.
Betamethasone+neomycin sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betamethasone+salicylic acid 0.05/3% scalp application	A component that fails to comply with the current editorial guidance.
Betatron electron therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betatron photon therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaxolol 0.25% conventional release eye drops	A component that fails to comply with the current editorial guidance.
Betaxolol 0.25% single-use eye drops	A component that fails to comply with the current editorial guidance.
Betaxolol hydrochloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaxolol hydrochloride 0.25% suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaxolol hydrochloride 0.5% solution	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betaxolol hydrochloride 2.5mg/mL suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bethanechol chloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bethanechol chloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bethylid wasp	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Betizuak cattle breed	Moved elsewhere
Better eye: low vision, Lesser eye: profound visual impairment	Ambiguous
Better eye: moderate visual impairment, Lesser eye: blind, unspecified	Ambiguous
Better eye: moderate visual impairment, Lesser eye: low vision unspecified	Limited component (foundation metadata concept)
Better eye: moderate visual impairment, Lesser eye: moderate visual impairment	Ambiguous
Better eye: moderate visual impairment, Lesser eye: near total visual impairment	Ambiguous
Better eye: moderate visual impairment, Lesser eye: profound visual impairment	Ambiguous
Better eye: moderate visual impairment, Lesser eye: severe visual impairment	Ambiguous
Better eye: moderate visual impairment, Lesser eye: total visual impairment	Ambiguous
Better eye: near total visual impairment, Lesser eye: near total visual impairment	Ambiguous
Better eye: near total visual impairment, Lesser eye: total visual impairment	Ambiguous
Better eye: near total visual impairment, Lesser eye: unspecified	Limited component (foundation metadata concept)
Better eye: profound visual impairment, Lesser eye: near total visual impairment	Ambiguous
Better eye: profound visual impairment, Lesser eye: profound visual impairment	Ambiguous
Better eye: profound visual impairment, Lesser eye: total visual impairment	Ambiguous
Better eye: profound visual impairment, Lesser eye: unspecified	Limited component (foundation metadata concept)
Better eye: severe visual impairment, Lesser eye: blind, unspecified	Ambiguous
Better eye: severe visual impairment, Lesser eye: low vision unspecified	Limited component (foundation metadata concept)
Better eye: severe visual impairment, Lesser eye: near total visual impairment	Ambiguous

Start Previous Page 164 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)